Djontu, Jean Claude
Baina, Marcel Tapsou
Ntabi, Jacques Dollon Mbama
Mapanguy, Claujens Chastel Mfoutou
Batchi-Bouyou, Armel Landry
Elenga, Viny Andzi
Kouikani, Franck Yannis
Ndala, Arcel Christ Massamba
Mouanga, Alain Maxime
Ntoumi, Francine
Funding for this research was provided by:
CANTAM ([EDCTPRegNet2015-1045])
Article History
Received: 20 May 2025
Accepted: 17 October 2025
First Online: 24 December 2025
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethic Committee of Fondation Congolaise pour la Recherche Médicale. Each volunteer gave written informed consent before participating in this investigation. For participants under18 years, informed consent to participate was obtained from their legal guardians. All malaria-positive patients were treated by the physician with artemisinin-based combination therapy (ACT) according to WHO and national malaria control program guidelines.
: No applicable.
: The authors declare no competing interests.